708 related articles for article (PubMed ID: 15364040)
1. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
2. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
3. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
Geracioti TD; Loosen PT; Ekhator NN; Schmidt D; Chambliss B; Baker DG; Kasckow JW; Richtand NM; Keck PE; Ebert MH
Depress Anxiety; 1997; 6(3):89-94. PubMed ID: 9442982
[TBL] [Abstract][Full Text] [Related]
5. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
Rush AJ; Marangell LB; Sackeim HA; George MS; Brannan SK; Davis SM; Howland R; Kling MA; Rittberg BR; Burke WJ; Rapaport MH; Zajecka J; Nierenberg AA; Husain MM; Ginsberg D; Cooke RG
Biol Psychiatry; 2005 Sep; 58(5):347-54. PubMed ID: 16139580
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
Kay AD; Schapiro MB; Riker AK; Haxby JV; Rapoport SI; Cutler NR
Ann Neurol; 1987 Apr; 21(4):408-11. PubMed ID: 2437853
[TBL] [Abstract][Full Text] [Related]
7. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
[TBL] [Abstract][Full Text] [Related]
8. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
Takahashi S; Abe T
No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
[TBL] [Abstract][Full Text] [Related]
9. Monoamines in the brain cerebrospinal fluid of facial pain patients.
Bouckoms AJ; Sweet WH; Poletti C; Lavori P; Carr D; Matson W; Gamache P; Aronin N
Anesth Prog; 1992; 39(6):201-8. PubMed ID: 7504420
[TBL] [Abstract][Full Text] [Related]
10. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
11. Stability of monoamine metabolites in human cerebrospinal fluid.
Langlais PJ; Bird ED; McEntee WJ
Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
[TBL] [Abstract][Full Text] [Related]
12. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
George MS; Rush AJ; Marangell LB; Sackeim HA; Brannan SK; Davis SM; Howland R; Kling MA; Moreno F; Rittberg B; Dunner D; Schwartz T; Carpenter L; Burke M; Ninan P; Goodnick P
Biol Psychiatry; 2005 Sep; 58(5):364-73. PubMed ID: 16139582
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
Ben-Menachem E; Persson LI; Mumford J; Haegele KD; Huebert N
J Child Neurol; 1991; Suppl 2():S11-6. PubMed ID: 1719063
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
Ogawa T; Nagao T; Kashiwabara K; Fujiwara Y; Harada T; Otsuki S
Clin Ther; 1984; 7 Spec No():1-17. PubMed ID: 6085032
[TBL] [Abstract][Full Text] [Related]
16. [Effects of idebenone on monoamine metabolites in the cerebrospinal fluid of patients with cerebrovascular dementia].
Kawakami M; Itoh T
No To Shinkei; 1986 Feb; 38(2):187-93. PubMed ID: 2421750
[TBL] [Abstract][Full Text] [Related]
17. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
Scheinin M
Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
[TBL] [Abstract][Full Text] [Related]
18. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
Petrakis IL; Trevisan L; D'Souza C; Gil R; Krasnicki S; Webb E; Heninger G; Cooney N; Krystal JH
Alcohol Clin Exp Res; 1999 Aug; 23(8):1336-41. PubMed ID: 10470976
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
[TBL] [Abstract][Full Text] [Related]
20. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
